The Journal of
Clinical Psychiatry

Volume 84 • 2023 • 4

Original Research

Predictors of Suicidal Ideation During Residential Substance Use Treatment

J Clin Psychiatry 2023;84(4):22m14611

Jennifer D. Ellis, PhD; Jill A. Rabinowitz, PhD; Justin C. Strickland, PhD; David Wolinsky, MD; Andrew S. Huhn, PhD, MBA

Original Research

The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis

J Clin Psychiatry 2023;84(4):22m14732

Joseph F. Goldberg, MD; Cynthia Siu, PhD; Michael Tocco, PhD; Andrei Pikalov, MD, PhD; Antony Loebel, MD

Original Research

Interpersonal Support Domains Associated With Symptoms of Posttraumatic Stress Among Older Black and White Adults

J Clin Psychiatry 2023;84(4):22m14634

Helene M. Altmann, MD; Marie Anne Gebara, MD; Steven M. Albert, PhD; Jennifer Q. Morse, PhD; Charles F. Reynolds III, MD; Stephen B. Thomas, PhD; Sarah T. Stahl, PhD

Original Research

The Challenge of Clinical Research and Suicidality: Participant Feedback on a Safety Protocol

J Clin Psychiatry 2023;84(4):22m14737

Rachel Vanderkruik, PhD, MSc; Marlene P. Freeman, MD; Katherine A. Dunn, BS; Charlotte A. Clifford, BA; Sona Dimidjian, PhD; Lee S. Cohen, MD

Original Research

Head-to-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy: Results of the VIVRE Study

J Clin Psychiatry 2023;84(4):23m14780

Roger S. McIntyre, MD; Ioana Florea, MD; Mads Møller Pedersen, MSc; Michael Cronquist Christensen, DrPH

3 and Marine Omega-3 Fatty Acids Supplementation on Indicated and Selective Prevention of Depression in Older Adults: Results From the Clinical Center Sub-Cohort of the VITamin D and OmegA-3 TriaL (VITAL)">

Original Research

Effects of Vitamin D₃ and Marine Omega-3 Fatty Acids Supplementation on Indicated and Selective Prevention of Depression in Older Adults: Results From the Clinical Center Sub-Cohort of the VITamin D and OmegA-3 TriaL (VITAL)

J Clin Psychiatry 2023;84(4):22m14629

Chirag M. Vyas, MBBS, MPH; David Mischoulon, MD, PhD; Grace Chang, MD, MPH; Nancy R. Cook, ScD; Alison Weinberg, MA; Trisha Copeland, MS, RD; Jae H. Kang, ScD; Vadim Bubes, PhD; Georgina Friedenberg, MPH; Meryl S. LeBoff, MD; I-Min Lee, MBBS, ScD; Julie E. Buring, ScD; JoAnn E. Manson, MD, DrPH; Charles F. Reynolds III, MD; Olivia I. Okereke, MD, SM

Original Research

Interdisciplinary Weight Loss and Lifestyle Intervention for Daily Functioning and Psychiatric Symptoms in Obstructive Sleep Apnea: The INTERAPNEA Randomized Clinical Trial

J Clin Psychiatry 2023;84(4):22m14502

Almudena Carneiro-Barrera, PhD; Francisco J. Amaro-Gahete, PhD; Germán Sáez-Roca, MD; Carlos Martín-Carrasco, MD; António Labisa Palmeira, PhD; Jonatan R. Ruiz, PhD

Original Research

Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder

J Clin Psychiatry 2023;84(4):22m14705

Ramin Mojtabai, MD, PhD, MPH; Masoumeh Amin-Esmaeili, MD, MPH; Stanislav Spivak, MD; Mark Olfson, MD, MPH

Original Research

Mild Vitamin C Deficiency Is Common in the Inpatient Psychiatric Setting

J Clin Psychiatry 2023;84(4):22m14616

Bilal A. Bari, MD, PhD; Ana Ivkovic, MD; Bryce A. Wininger, MD

Original Research

Leveraging Natural Language Processing to Improve Electronic Health Record Suicide Risk Prediction for Veterans Health Administration Users

J Clin Psychiatry 2023;84(4):22m14568

Maxwell Levis, PhD; Joshua Levy, PhD; Kallisse R. Dent, MPH; Vincent Dufort, PhD; Glenn T. Gobbel, PhD, DVM, MS; Bradley V. Watts, MD, MPH; Brian Shiner, MD, MPH

Original Research

Differential Effects of an Intervention to Reduce Cardiovascular Risk for Patients With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Randomized Clinical Trial

J Clin Psychiatry 2023;84(4):22m14710

Rebecca C. Rossom, MD, MS; A. Lauren Crain, PhD; Stephen Waring, DVM, PhD; JoAnn M. Sperl-Hillen, MD; Stephanie A. Hooker, PhD, MPH; Kathleen Miley, PhD, MSN; Patrick J. O’Connor, MD, MA, MPH

Original Research

Response and Safety Outcomes in Treatment-Resistant Depression After Subcallosal Cingulate Gyrus Deep Brain Stimulation: Long-term Follow-up Study

J Clin Psychiatry 2023;84(4):22m14622

Carlo Alemany, MD; Dolors Puigdemont, MD, PhD; Ana Martín-Blanco, MD, PhD; Rodrigo Rodríguez-Rodríguez, MD, PhD; Juan A. Aibar-Durán, MD; Muriel Vicent-Gil, PhD; Enric Alvarez, MD, PhD; Víctor Pérez, MD, PhD; María J. Portella, PhD; Javier de Diego-Adeliño, MD, PhD

Original Research

Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database

J Clin Psychiatry 2023;84(4):22m14734

Justine Benevent, PharmD, PhD; Mélanie Araujo, Master; Sudip Karki, Master; Caroline Delarue-Hurault, PhD; Julie Waser, Master; Isabelle Lacroix, PharmD, PhD; Sarah Tebeka, MD, PhD; Christine Damase-Michel, PharmD, PhD

A Prospective Study of the Mediating Role of Tonic Immobility and Peritraumatic Dissociation on the 4 <strong data-src=

DSM-5 Symptom Clusters of Posttraumatic Stress Disorder">

Original Research

A Prospective Study of the Mediating Role of Tonic Immobility and Peritraumatic Dissociation on the 4 DSM-5 Symptom Clusters of Posttraumatic Stress Disorder

J Clin Psychiatry 2023;84(4):22m14613

Sarah Bøgelund Dokkedahl, PhD; Yael Lahav, PhD

Original Research

Predicting Remission From Depression in Youth Receiving Outpatient Medication Management

J Clin Psychiatry 2023;84(4):22m14581

Kennedy M. Balzen, BS; Jane K. Hensley, MRC; Paul A. Nakonezny, PhD; Jessica Jones, MA; Betsy D. Kennard, PsyD; Graham J. Emslie, MD

Systematic Review

What’s Stopping Us? Using GnRH Analogs With Stable Hormone Addback in Treatment-Resistant Premenstrual Dysphoric Disorder: Practical Guidelines and Risk-Benefit Analysis for Long-term Therapy

J Clin Psychiatry 2023;84(4):22r14614

Melissa Wagner-Schuman, MD, PhD; Alyssa Kania, MD; Jordan C. Barone, BA; Jaclyn M. Ross, PhD; Ashley Mulvihill, MD; Tory A. Eisenlohr-Moul, PhD

Academic Highlights

Racial and Ethnic Disparities in Physical and Mental Health Care and Clinical Trials

J Clin Psychiatry 2023;84(4):23ah14887

Inez Ruiz-White, PhD; Luke Kramer, BA; Lionel Philips, MBA; Becky Wong, PharmD, MBA; Kimberly Lonergan, MSN; Francisco Moreno, MD

Commentary

Determining Clinical Follow-Up in the Context of Widening LAI Intervals: How Long Is Too Long?

J Clin Psychiatry 2023;84(4):23com14680

Samuel J. Dotson, MD; Robert O. Cotes, MD; Oliver Freudenreich, MD

Educational Activity

Emerging Therapies for Attention-Deficit/Hyperactivity Disorder

J Clin Psychiatry 2023;84(4):muladhd3048sho

Jeffrey H. Newcorn, MD

Educational Activity

Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management

J Clin Psychiatry 2023;84(4):sunscz3001sho

Leslie Citrome, MD, MPH; Jonathan M. Meyer, MD

Educational Activity

Staying Up to Date With Evolving Postpartum Depression Pathophysiology and Treatment Research

J Clin Psychiatry 2023;84(4):sagppd3003sho

Kristina M. Deligiannidis, MD; Rubiahna Vaughn, MD, MPH

Educational Activity

Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy

J Clin Psychiatry 2023;84(4):mulmdd3048sho

Michael E. Thase, MD

Educational Activity

Emerging Perspectives in Addiction Psychiatry

J Clin Psychiatry 2023;84(4):muladx3048sho

Ayana Jordan, MD, PhD

Brief Report

Cardiac Malformation Risks Following Maternal First Trimester Methylphenidate Use

J Clin Psychiatry 2023;84(4):22br14755

Jonathan L. Richardson, PhD; Nathan George, BSc; Amanda J. Greenall, PhD; Alison M. Oliver, PhD; Sally Stephens, PhD; Kenneth K. Hodson, MBChB, MD, MRCP, MRCOG

Letter to the Editor

Potential Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

J Clin Psychiatry 2023;84(4):23lr14892

Laura Palagini, MD, PhD; Pierre A. Geoffroy, MD, PhD; Jean Arthur Micoulaud-Franchi, MD, PhD; Angelo Gemignani, MD, PhD; Dieter Riemann, PhD

Letter to the Editor

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

J Clin Psychiatry 2023;84(4):23lr14892a

Bénédicte Nobile, PharmD, PhD; Philippe Courtet, MD, PhD

Letter to the Editor

“Can We Deliver TMS to Patients With Implanted Devices?” A Practical Summary of the Recent Safety Recommendations

J Clin Psychiatry 2023;84(4):23l14857

Aron Tendler, MD; Yiftach Roth, PhD; Colleen A. Hanlon, PhD

Clinical and Practical Psychopharmacology

Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Questionably Significant Benefits

J Clin Psychiatry 2023;84(4):23f15009

Chittaranjan Andrade, MD

Clinical and Practical Psychopharmacology

How to Use Percentiles to Better Understand Standardized Mean Difference (SMD) as a Measure of Effect Size

J Clin Psychiatry 2023;84(4):23f15028

Chittaranjan Andrade, MD

Volume 84 • 2023 • 4

Original Research

Predictors of Suicidal Ideation During Residential Substance Use Treatment

The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis

Interpersonal Support Domains Associated With Symptoms of Posttraumatic Stress Among Older Black and White Adults

The Challenge of Clinical Research and Suicidality: Participant Feedback on a Safety Protocol

Head-to-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy: Results of the VIVRE Study

Effects of Vitamin D₃ and Marine Omega-3 Fatty Acids Supplementation on Indicated and Selective Prevention of Depression in Older Adults: Results From the Clinical Center Sub-Cohort of the VITamin D and OmegA-3 TriaL (VITAL)

Interdisciplinary Weight Loss and Lifestyle Intervention for Daily Functioning and Psychiatric Symptoms in Obstructive Sleep Apnea: The INTERAPNEA Randomized Clinical Trial

Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder

Mild Vitamin C Deficiency Is Common in the Inpatient Psychiatric Setting

Leveraging Natural Language Processing to Improve Electronic Health Record Suicide Risk Prediction for Veterans Health Administration Users

Differential Effects of an Intervention to Reduce Cardiovascular Risk for Patients With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Randomized Clinical Trial

Response and Safety Outcomes in Treatment-Resistant Depression After Subcallosal Cingulate Gyrus Deep Brain Stimulation: Long-term Follow-up Study

Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database

A Prospective Study of the Mediating Role of Tonic Immobility and Peritraumatic Dissociation on the 4 DSM-5 Symptom Clusters of Posttraumatic Stress Disorder

Predicting Remission From Depression in Youth Receiving Outpatient Medication Management

Systematic Review

What’s Stopping Us? Using GnRH Analogs With Stable Hormone Addback in Treatment-Resistant Premenstrual Dysphoric Disorder: Practical Guidelines and Risk-Benefit Analysis for Long-term Therapy

Academic Highlights

Racial and Ethnic Disparities in Physical and Mental Health Care and Clinical Trials

Commentary

Determining Clinical Follow-Up in the Context of Widening LAI Intervals: How Long Is Too Long?

Educational Activity

Emerging Therapies for Attention-Deficit/Hyperactivity Disorder

Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management

Staying Up to Date With Evolving Postpartum Depression Pathophysiology and Treatment Research

Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy

Emerging Perspectives in Addiction Psychiatry

Brief Report

Cardiac Malformation Risks Following Maternal First Trimester Methylphenidate Use

Letter to the Editor

Potential Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

“Can We Deliver TMS to Patients With Implanted Devices?” A Practical Summary of the Recent Safety Recommendations

Clinical and Practical Psychopharmacology

Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Questionably Significant Benefits

How to Use Percentiles to Better Understand Standardized Mean Difference (SMD) as a Measure of Effect Size

ELSEWHERE:

FOLLOW US:

Volume 84 • 2023 • 4

Original Research

Predictors of Suicidal Ideation During Residential Substance Use Treatment

The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis

Interpersonal Support Domains Associated With Symptoms of Posttraumatic Stress Among Older Black and White Adults

The Challenge of Clinical Research and Suicidality: Participant Feedback on a Safety Protocol

Head-to-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy: Results of the VIVRE Study

Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Indicated and Selective Prevention of Depression in Older Adults: Results From the Clinical Center Sub-Cohort of the VITamin D and OmegA-3 TriaL (VITAL)

Interdisciplinary Weight Loss and Lifestyle Intervention for Daily Functioning and Psychiatric Symptoms in Obstructive Sleep Apnea: The INTERAPNEA Randomized Clinical Trial

Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder

Mild Vitamin C Deficiency Is Common in the Inpatient Psychiatric Setting

Leveraging Natural Language Processing to Improve Electronic Health Record Suicide Risk Prediction for Veterans Health Administration Users

Differential Effects of an Intervention to Reduce Cardiovascular Risk for Patients With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Randomized Clinical Trial

Response and Safety Outcomes in Treatment-Resistant Depression After Subcallosal Cingulate Gyrus Deep Brain Stimulation: Long-term Follow-up Study

Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database

A Prospective Study of the Mediating Role of Tonic Immobility and Peritraumatic Dissociation on the 4 DSM-5 Symptom Clusters of Posttraumatic Stress Disorder

Predicting Remission From Depression in Youth Receiving Outpatient Medication Management

Systematic Review

What’s Stopping Us? Using GnRH Analogs With Stable Hormone Addback in Treatment-Resistant Premenstrual Dysphoric Disorder: Practical Guidelines and Risk-Benefit Analysis for Long-term Therapy

Academic Highlights

Racial and Ethnic Disparities in Physical and Mental Health Care and Clinical Trials

Commentary

Determining Clinical Follow-Up in the Context of Widening LAI Intervals: How Long Is Too Long?

Educational Activity

Emerging Therapies for Attention-Deficit/Hyperactivity Disorder

Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management

Staying Up to Date With Evolving Postpartum Depression Pathophysiology and Treatment Research

Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy

Emerging Perspectives in Addiction Psychiatry

Brief Report

Cardiac Malformation Risks Following Maternal First Trimester Methylphenidate Use

Letter to the Editor

Potential Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

“Can We Deliver TMS to Patients With Implanted Devices?” A Practical Summary of the Recent Safety Recommendations

Clinical and Practical Psychopharmacology

Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Questionably Significant Benefits

How to Use Percentiles to Better Understand Standardized Mean Difference (SMD) as a Measure of Effect Size

Celebrating85 Years

Subscribe to readmore articles

Effects of Vitamin D₃ and Marine Omega-3 Fatty Acids Supplementation on Indicated and Selective Prevention of Depression in Older Adults: Results From the Clinical Center Sub-Cohort of the VITamin D and OmegA-3 TriaL (VITAL)

Celebrating
85 Years

Subscribe to read
more articles